Clinical Trial Update: Tedizolid Phosphate (TR-701 FA, MK-1986) vs Linezolid for the Treatment of Nosocomial Pneumonia (MK-1986-002) [Phase 3]

View source ↗

Summary

Phase 3 trial comparing Tedizolid Phosphate (MK-1986) to Linezolid for nosocomial pneumonia has completed with posted results.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pneumonia

Drugs mentioned

• Linezolid (Linezolid)
• Tedizolid Phosphate (tedizolid phosphate)

Snippet

Sponsor: Cubist Pharmaceuticals LLC, a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA) | Conditions: Pneumonia | Phase 3 | Status: COMPLETED | Results posted: 2019-06-27